Data will be available to researchers studying a wide range of disease states BOULDER, Colo. — SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that the company will begin assaying samples from the Multi-Ethnic Study of Atherosclerosis (MESA) study beginning in the first quarter of 2022. SomaLogic will use its industry-leading assay […]
The platform packages advanced high-throughput, cell-free protein manufacturing and protein design technologies in an easy-to-use online shopping portal for synthetic biologists, drug developers and researchers working on everything from petrochemical-free fashion/textiles and cruelty-free cosmetics to novel flavors and aromas for FoodTech. SAN LEANDRO, Calif. — Tierra Biosciences today announced the launch of the Tierra Protein […]
CAMBRIDGE, UK – Nuclera, a biotech company developing cutting-edge benchtop protein printing technologies, today announced that the first close of its Series B financing has raised $42.5 million. The funds raised will be used to accelerate the development and commercialization of its eProtein™ desktop bioprinter. Nuclera’s ground-breaking protein printing technology has attracted many new and existing institutional […]
BOSTON — NanoMosaic Inc., the pioneer and leader in nanoneedle (MosaicNeedle™) technology detection for proteomics, genomics, and single-run experiment multi-omics applications, has announced that it has officially opened its “Proteomics/Multi-Omics Early Access Program,” to life science researchers and to CLIA certified labs developing diagnostic applications. The Company is making a limited number of systems available […]
Key appointment will support the company’s commercial growth plans to deliver proteomics and protein innovations worldwide BURLINGAME, Calif. — Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today announced the addition of Katy Miles to its Board of Directors, effective as of February 1, 2022. She joins recent addition David Smoller, General Partner […]
Abcam to license in VHH phage library(1) from Twist, complementing in-house recombinant antibody capabilities Abcam to develop and commercialize antibodies for diagnostic and research use, with Twist retaining rights for therapeutic applications Reinforces Abcam’s commitment to consistently improve industry standards and support the sector with best-in-class reagents CAMBRIDGE, England & SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ:TWST), […]
LEXINGTON, Ky. — NEOGEN Corporation (NASDAQ: NEOG) announced today that it has added a new chemiluminescent substrate as part of the trusted K-Blue® product line. K-Blue Luminescent is a two-component, luminol-based substrate that offers high sensitivity, ranging from the nanogram down to the femtogram level. This new formula is optimized to emit maximum light at […]
Biotech company recognized for culture supporting work-life balance Madison, WI USA. — Promega Corporation was recognized today as a top place to work in the US with a 2022 Top Workplaces USA award. Companies earn a place on the Top Workplaces USA list based solely on employee engagement surveys compiled by research firm Energage. More […]
HERCULES, Calif. – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today introduced four inhibitory antibodies that are highly specific to pertuzumab (Perjeta). These ready-made antibodies inhibit the binding of the drug to its target, human epidermal growth factor 2 (HER2), enabling researchers to develop […]
CINCINNATI — Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that John C. McIlwraith has been elected as Chairman of the Meridian Board of Directors, effective January 26, 2022. Mr. McIlwraith succeeds David C. Phillips, who retired after serving for more than 21 […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
